25 years have passed since HIV therapies were approved for people living with the virus, but people who are HIV positive are often excluded from cancer clinical trials. Why is that?
Writer Tim Murphy explored that question, and argues that not only is the practice discriminatory, but it's putting lives at risk. We talk with him about what he learned. Our guests:
- Tim Murphy, contributing editor for the Body Pro
- Ariela Noy, M.D., attending physician and member in the Department of Medicine/Lymphoma Service at Memorial Sloan Kettering Cancer Center
